BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 427349)

  • 1. Scintigraphic assessment of technetium 99m-diphosphonate uptake, vascularity and vessel permeability in human bone tumours.
    Front D; Hardoff R; Iosilevsky G
    Br J Radiol; 1979 Jan; 52(613):34-5. PubMed ID: 427349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal lung uptake of technetium 99m methylene diphosphonate associated with pulmonary emboli and hypercalcaemia.
    Wraight EP
    Br J Radiol; 1983 May; 56(665):345-7. PubMed ID: 6221773
    [No Abstract]   [Full Text] [Related]  

  • 3. A computer assisted comparison of 99Tcm-methylene-diphosphonate and 99Tcm-pyrophosphate bone imaging.
    Büll U; Pfeifer JP; Niendorf HP; Tongendorff J
    Br J Radiol; 1977 Sep; 50(597):629-36. PubMed ID: 198055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of skeletal uptake of 99mTc-diphosphonate over a five day period.
    Fogelman I; Martin W
    Eur J Nucl Med; 1983; 8(11):489-90. PubMed ID: 6653609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scintigraphic evaluation of giant cell tumor of bone.
    Levine E; De Smet AA; Neff JR; Martin NL
    AJR Am J Roentgenol; 1984 Aug; 143(2):343-8. PubMed ID: 6234786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic uptake of technetium-99m diphosphonate in thalassemia major.
    Levy HM; Smith R
    Clin Nucl Med; 1986 Feb; 11(2):110-2. PubMed ID: 3769335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased uptake of technetium-99m-labeled bone imaging agents in the kidneys.
    Siddiqui AR
    Semin Nucl Med; 1982 Jan; 12(1):101-2. PubMed ID: 6210961
    [No Abstract]   [Full Text] [Related]  

  • 8. Doughnut phenomenon in bone scintigraphy.
    Front D; Hardoff R
    Clin Nucl Med; 1978 Mar; 3(3):82-4. PubMed ID: 657672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone scintigraphy in chondroblastoma.
    Humphry A; Gilday DL; Brown RG
    Radiology; 1980 Nov; 137(2):497-9. PubMed ID: 6449026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radionuclide bone scanning of medullary chondrosarcoma.
    Hudson TM; Chew FS; Manaster BJ
    AJR Am J Roentgenol; 1982 Dec; 139(6):1071-6. PubMed ID: 6216791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Whole-body retention of 99mTc-methylene diphosphonate in skeletal diseases].
    Zorn-Bopp E; Büll U; Münzing W; Lang P; Moser EA
    Nuklearmedizin; 1983 Feb; 22(1):24-30. PubMed ID: 6223277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of skeletal blood flow in determining the uptake of 99mTc-methylene diphosphonate.
    McCarthy ID; Hughes SP
    Calcif Tissue Int; 1983 Jul; 35(4-5):508-11. PubMed ID: 6225500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scintigraphic assessment of vascularity and blood-tissue barrier of human brain tumours.
    Front D
    J Neurol Neurosurg Psychiatry; 1978 Jan; 41(1):18-23. PubMed ID: 621527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bone metastasis of lung cancer: "Cold" bone lesion on bone imaging with 99mTc-diphosphonate (author's transl)].
    Ohsawa T; Kanno T; Nobesawa S; Fujii T; Yamamura N; Ohta M
    Rinsho Hoshasen; 1979; 24(2):315-9. PubMed ID: 430897
    [No Abstract]   [Full Text] [Related]  

  • 17. Accumulation of Tc-99m diphosphonate in pericardial effusion.
    Yeh EL; Thompson MA; Meade RC
    J Nucl Med; 1979 Oct; 20(10):1102-3. PubMed ID: 536768
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative evaluation of three diphosphonates: in vitro adsorption (C- 14 labeled) and in vivo osteogenic uptake (Tc-99m complexed).
    Francis MD; Ferguson DL; Tofe AJ; Bevan JA; Michaels SE
    J Nucl Med; 1980 Dec; 21(12):1185-9. PubMed ID: 6449567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technetium-99m phytate as a bone-marrow imaging agent: biodistribution studies in animals: concise communication.
    Hamilton RG; Alderson PO; Mclntyre PA
    J Nucl Med; 1977 Jun; 18(6):563-5. PubMed ID: 859038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative investigations of osteotropic radionucleides. IV. The dynamics of uptake in normal and abnormal bone (author's transl)].
    Creutzig H; Gerdts KG; Creutzig A
    Rofo; 1977 Mar; 126(3):258-62. PubMed ID: 139345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.